Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 26, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% and 0.5%.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 26, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% and 0.5%.".